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isodisomy of chromosome 17 and the first
example of UPD underlying JEB-PA.
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CD44-Deficient Mice Do Not Exhibit Impairment of
Epidermal Langerhans Cell Migration to Lymph Nodes
after Epicutaneous Sensitization with Protein
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TO THE EDITOR
CD44 is a type I transmembrane protein
that binds extracellular matrix nonsul-
fated glycosaminoglycan hyaluronan
and has an important role in cell
adhesion and migration (Isacke, 2002).
Thus, CD44 is involved with leukocyte
egress, tumor invasiveness, and metas-
tasis (Isacke, 2002).
The role of CD44 in epidermal
Langerhans cell (LC) migration to drain-
ing lymph nodes (LNs) was first eval-
uated by an antibody blocking system.
Antibodies against CD44 epitopes
inhibited emigration of LCs from the
epidermis and prevented cultured LC
binding to T-cell zones in LN-frozen
sections (Weiss et al., 1997). In a
CD44-deficient mouse system, CD44
deficiency did not impair LC emigration
from the epidermis, but significantly
influenced their LN homing (Mummert
et al., 2004). In recent years, there has
been significant progress in understand-
ing the characteristics and kinetics
of LCs. It is known that there are two
kinds of Langerinþ dendritic cells
(DCs) (definition of LCs): one resides
in the epidermis and another resides
in the dermis (Bursch et al., 2007).
They show different migration patterns
to draining LNs after immunization.
Dermal Langerinþ DC migration peaks
early at 24 hours, whereas peak migra-
tion of epidermal LC is delayed untilAbbreviations: DC, dendritic cell; LC, Langerhans cell; LN, lymph node; Th, T helper
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4 days after immunization (Shklovskaya
et al., 2008). As previous reports failed
to define LCs by specific markers
and analyzed LNs for no more than
3 days, we sought to re-evaluate the
migration of epidermal LCs in CD44-
deficient mice using a well-established
protein-patch model (Chen et al.,
2009). Protein antigens rather than
haptens were chosen because protein
antigens will cross the keratin barrier
much slower, owing to their larger
size and hydrophilic character, thus
giving a bigger chance for epidermal
LCs to capture and present them. All
animal experiments were approved
by the Animal Care Committee of the
Medical College of National Taiwan
University. Both CD44-deficient (P256)
and wild-type C57BL/6 mice were
from the National Mouse Mutagenesis
Program Care Facility of Academia
Sinica. A T to A transversion mutation
within exon 2 caused a premature
termination that resulted in a severely
truncated 72-amino-acid CD44 protein,
instead of the 778-residue wild-
type CD44 protein (Figure 1a and b).
Trans-splicing of mRNA between exon
1 and other parts of the standard region
of CD44, which will escape the
premature termination in exon 2, did
not occur in P256 mice as monitored
by reverse transcriptase-PCR ampli-
fication between exon 1 and exon 5
(Figure 1c).
First, the numbers of Langerinþ DCs
in draining LNs of naive CD44-deficient
and wild-type C57BL/6 mice were
examined. The numbers of CD8þ DCs
and total CD11cþ DCs were also
measured for reference. For this, an LN
cell suspension was positively selected
for CD11cþ cells and stained with
various combinations of CD11c, Langer-
in (intracellular), and CD8. Naive CD44-
deficient and wild-type mice showed
comparable numbers of Langerinþ DCs,
CD8þ DCs, and total CD11cþ DCs in
their LNs (Figure 1d). Next, we examined
the number of Langerinþ DCs at 4 days
after epicutaneous sensitization with
protein antigen, which was the peak
time point when epidermal LCs arrived
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Figure 1. Numbers of dendritic cells (DCs) in draining lymph nodes (LNs). (a) CD44 staining of peripheral blood leucocytes of CD44þ /þ (dash),
CD44P256/þ (dotted), and CD44P256/P256 (solid) mice, and unstained control (shaded) are shown. (b) All CD44 exons were subjected to DNA sequencing,
and a T-to-A transversion mutation within exon 2 was found (asterisk denotes premature termination). (c) Reverse transcriptase-PCR amplification between
exon 1 and exon 5. (d, e, g) Draining LNs were isolated from naive mice (d) or 96 hours after immunization (e, g). CD11cþ cells were gated. Results are
expressed as numbers per six draining LNs per mouse. The pooled data of three to five experiments are shown. (f) LNs were isolated from CD44-deficient mice
96hours after patch application of ovalbumin (OVA) (dash) or OVA-DQ (solid). Langerinþ cells were gated. (g) Langerinhigh CD103 DCs were gated.
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in draining LNs. As shown in Figure 1e,
CD44-deficient mice had higher num-
bers of CD11cþ DCs in draining LNs
compared with wild-type mice. Wilcox-
on’s rank sum test was used to test the
significance of difference. The P-value
for CD11cþ DC was 0.0079. The
numbers of Langerinþ DCs in CD44-
deficient mice also seemed to be higher
than those in wild-type mice. However,
it did not reach statistical significance.
To confirm that these Langerinþ DCs
were skin-derived, fluorescence-conju-
gated ovalbumin (OVA-DQ) was used.
Figure 1f shows that Langerinþ DCs in
draining LNs carried this fluorescent
marker. We also checked the expres-
sions of costimulating molecules on
Langerinþ DCs in draining LNs at
96hours after epicutaneous sensitization
with protein antigen. Langerinþ DCs in
draining LNs in CD44-deficient mice
showed comparable expressions of
CD80, CD86, CD24, and CD40 with
those in wild-type mice (data not
shown). Recently, it was recognized that
epidermal Langerinþ DCs (LCs) and
dermal Langerinþ DCs could be distin-
guished on the basis of their expressions
of CD103 (Merad et al., 2008). Figure 1g
shows that the numbers of CD103
Langerinhigh DCs, which indicated epi-
dermal LCs in draining LNs 96hours
after epicutaneous immunization,
were comparable in CD44-deficient
and wild-type mice. The discrepancy
between the results of Langerinþ DCs
and CD103 Langerinhigh DCs could be
because of variations in CD103high
Langerinhigh dermal DCs and CD103low
CD8þ Langerinlow resident DCs. Taken
together, these results show that CD44-
deficient mice do not exhibit impairment
of epidermal LC migration to LNs after
epicutaneous sensitization with protein
antigen.
We next checked T-cell immune
responses in CD44-deficient mice using
two prototypic experimental systems.
Epicutaneous sensitization with protein
antigen induces a predominant T helper
(Th)2 response, whereas subcutaneous
immunization induces a vigorous Th1
response. At 10 days after the start of
immunization, drained LNs were iso-
lated and used for in vitro antigen
reactivation cultures. The interleukin-5
and interleukin-13 levels in superna-
tants of CD44-deficient mice with
ovalbumin patch applications were al-
ways higher compared with those of
wild-type mice (Figure 2a). However,
the interferon-g levels in supernatants of
CD44-deficient mice after subcuta-
neous immunization with ovalbumin
plus complete Freund’s adjuvant (CFA)
were also higher than those from wild-
type mice (Figure 2b). Thus, T-cell
immune responses of CD44-deficient
mice are not Th1 or Th2 biased. In
contrast, CD44-deficient mice showed
stronger predominant Th responses
after immunization.
Recently, CD44 was found to be a
phagocytic receptor and involved in the
resolution of noninfectious tissue inflam-
mation by mediating the clearance of
fragmented hyaluronan (Teder et al.,
2002; Vachon et al., 2006). However,
it is unlikely that these characteristics
contributed to our results. First, we used
gentle shaving to avoid harming the skin
and applied patches without previous
tape stripping or adding adjuvant.
Thus, the protein-patch model that we
established one decade ago examined
epicutaneous sensitization under phy-
siological, noninflammatory cutaneous
conditions. Second, because fragmented
hyaluronan can activate DCs, our results
showing comparable expressions of
costimulatory molecules on Langerinþ
DCs support the notion that the patched
skin of CD44-deficient mice was nonin-
flammatory. Third, CD44-deficient mice
exhibit unremitting inflammation 7 days
after injury, which was beyond our
immunization schedule.
In summary, by using specific
markers and an optimal time point, this
study unexpectedly showed that CD44-
deficient mice do not exhibit impair-
ment of epidermal LC migration to LNs
after epicutaneous sensitization with
protein antigen.
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Figure 2. T-cell responses in CD44-deficient and wild-type C57BL/6 mice. Groups of CD44-deficient or wild-type mice were immunized by (a) patch
application with ovalbumin (OVA) solution or phosphate-buffered saline control for 5 successive days or (b) subcutaneous injection with OVA plus complete
Freund’s adjuvant on day 1. At 10 days after immunization, draining lymph nodes (LNs) were isolated and in vitro OVA reactivation cultures were done. IFN-g,
IL-5, and IL-13 levels in 48-hour supernatants were determined by ELISA. Net concentration (concentration in the absence of OVA subtracted from the
concentration in the presence of OVA) is shown. Representative results from three independent experiments are shown.
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Hair Follicles from Alopecia Areata Patients Exhibit
Alterations in Immune Privilege-Associated
Gene Expression in Advance of Hair Loss
Journal of Investigative Dermatology (2010) 130, 2677–2680; doi:10.1038/jid.2010.180; published online 8 July 2010
TO THE EDITOR
Alopecia areata (AA) is a putative
autoimmune hair loss disease. Anagen-
stage hair follicles may have immune
privilege (Billingham and Silvers, 1971)
comprising downregulation of major
histocompatibility complex (MHC) class
I and II and production of immunoregu-
latory agents (Paus et al., 2003, 2005; Ito
et al., 2004). Of several hypotheses for
AA pathogenesis (McElwee et al., 2002;
Gilhar et al., 2007), one suggests that AA
is a consequence of immune privilege
collapse (Paus et al., 2003; Ito et al.,
2004). Although immunohistological
studies on immune privilege in AA have
been performed (McDonagh et al.,
1993; Ito et al., 2004), expression has
not been objectively quantified and
some immune privilege factors have
not been investigated. We conducted
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Figure 1. Differential expression of immune privilege-associated genes in the lesional margin of alopecia
areata (AA)-affected patches and the perilesional scalp hair follicles as compared with normal scalp
specimens. Quantitative PCR (qPCR) revealed apparent marked increased expression of IL1 receptor
antagonist (IL1Ra), CD80, and macrophage inhibitory factor (MIF) in lesional margin hair follicle bulbs. Red/
IK cytokine was significantly downregulated in the lesional margin. The fold change of gene expression was
analyzed by qPCR and was calculated using the formula 2DDCt, using perilesional and lesional hair follicles
from four AA patients versus normal hair follicles from four controls with X20 hair follicles per biopsy, and
qPCR analysis was conducted in triplicate. Error bars represent the range factor difference (2DDCt±DCt
standard deviation). *Indicates Po0.05 by Student’s t-test. The y axis is in log10 scale.
Abbreviations: AA, alopecia areata; MHC, major histocompatibility complex
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